Akebia Therapeutics (AKBA) Depreciation Expense (2019 - 2025)
Historic Depreciation Expense for Akebia Therapeutics (AKBA) over the last 6 years, with Q3 2025 value amounting to $318000.0.
- Akebia Therapeutics' Depreciation Expense fell 1239.67% to $318000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 1564.76%. This contributed to the annual value of $1.5 million for FY2024, which is 776.03% down from last year.
- Akebia Therapeutics' Depreciation Expense amounted to $318000.0 in Q3 2025, which was down 1239.67% from $316000.0 recorded in Q2 2025.
- Akebia Therapeutics' Depreciation Expense's 5-year high stood at $408000.0 during Q4 2022, with a 5-year trough of $314000.0 in Q1 2025.
- In the last 4 years, Akebia Therapeutics' Depreciation Expense had a median value of $379000.0 in 2023 and averaged $366916.7.
- In the last 5 years, Akebia Therapeutics' Depreciation Expense surged by 75.57% in 2024 and then tumbled by 2100.0% in 2025.
- Over the past 4 years, Akebia Therapeutics' Depreciation Expense (Quarter) stood at $408000.0 in 2022, then dropped by 3.43% to $394000.0 in 2023, then dropped by 14.97% to $335000.0 in 2024, then dropped by 5.07% to $318000.0 in 2025.
- Its Depreciation Expense was $318000.0 in Q3 2025, compared to $316000.0 in Q2 2025 and $314000.0 in Q1 2025.